Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
Clinical trial NCT02182505 · COMPLETED
Trial details
- NCT number
- NCT02182505
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-09-01
- Primary completion
- 1999-07-01
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.